Search Results 691-700 of 17583 for Assay

  1. Clinical trials - Oncology (Medical)

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  2. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

    ... assay within 9 months of symptom onset * Historically known positivity to an intracellular antigen with high cancer association or GAD-65 * Historically ...

  3. Brain Tumor Program - Clinical trials

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  4. A Study to Evaluate Hyperthermic Intraperitoneal Chemotherapy to Treat Patients with Pancreatic Cancer and Peritoneal Metastasis - Mayo Clinic

    KRASD assay positive peritoneal washings/cytology. Completion of preoperative systemic chemotherapy with biochemical, metabolic, and/or radiographic ...

  5. Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

    ... assay for any of the approved biologics above, there is no minimum washout prior to Baseline. * Participant who have any of the following: Current diagnosis ...

  6. Living-Donor Kidney Transplant Clinical Trials - Mayo Clinic Research

    The purpose of this study is to validate the use of an RNA-seq based peripheral blood assay in renal transplant recipients in adult kidney transplant recipients ...

  7. Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal Women With ER/PR+ Metastatic Breast Cancer - Mayo Clinic

    ... assay < 20 pg/mL oSurgical menopause with bilateral oophorectomy. Note: Ovarian radiation or treatment with a luteinizing hormone-releasing hormone agonist ...

  8. Brain Tumor Program - Clinical trials

    Rochester, Minn. Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies. cfDNA Assay Prospective Observational Validation for ...

  9. A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    failed laboratory assay, the patient is not eligible - Note: When determining CLL-IPI, use most recent test results, if more than one result is available

  10. Clinical trials - Oncology (Medical)

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...